What do systematic reviews say?

Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone

The review found no eligible studies for this question.

• Methotrexate for juvenile idiopathic arthritis 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Methotrexate vs alternative disease‐modifying antirheumatic drugs

• Methotrexate for juvenile idiopathic arthritis 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 94 participants
  Low

Methotrexate vs placebo

Methotrexate showed no clear difference in participant global assessment of well‐being(up to 6 months) compared with placebo (low certainty).

• Methotrexate for juvenile idiopathic arthritis 2024 · Cochrane Headline outcomes only
  RR 1.23 [0.88, 1.72]
  1 study · 176 participants
  Low

Summary of findings table ‐ Rehabilitation‐related activity interventions vs usual care with or without sham interventions

• Exercise for acutely hospitalised older medical patients 2022 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Summary of findings table ‐ Structured exercise interventions vs usual care with or without sham interventions

• Exercise for acutely hospitalised older medical patients 2022 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Summary of findings table ‐ Progressive resistance exercise interventions vs usual care with or without sham interventions

• Exercise for acutely hospitalised older medical patients 2022 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Exercise vs usual care with or without sham interventions

• Exercise for acutely hospitalised older medical patients 2022 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Summary of findings table ‐ Adjunctive therapies in addition to land‐based exercise therapy vs land‐based exercise therapy

Summary of findings table ‐ Adjunctive therapies in addition to… probably leads to higher participant‐reported global assessment‐ total compared with land‐based exercise therapy (moderate certainty).

• Adjunctive therapies in addition to land‐based exercise therapy for osteoarthritis of the hip or knee 2022 · Cochrane Headline outcomes only
  RR 1.37 [1.15, 1.62]
  5 studies · 840 participants
  Moderate

Summary of findings table ‐ Adjunctive therapies in addition to land‐based exercise therapy vs placebo adjunctive therapies

• Adjunctive therapies in addition to land‐based exercise therapy for osteoarthritis of the hip or knee 2022 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

High‐dose vs low‐dose colchicine

High‐dose showed no clear difference in participant global assessment of treatment success: proportion with… compared with low‐dose colchicine (low certainty).

• Colchicine for acute gout 2021 · Cochrane Headline outcomes only
  RR 0.87 [0.56, 1.36]
  1 study · 126 participants
  Low

Low‐dose colchicine vs placebo

Low‐dose colchicine may leads to higher participant global assessment of treatment success: proportion with… compared with placebo (low certainty).

• Colchicine for acute gout 2021 · Cochrane Headline outcomes only
  RR 2.43 [1.05, 5.64]
  1 study · 103 participants
  Low

Low‐dose colchicine vs NSAIDs

Low‐dose colchicine showed no clear difference in participant global assessment of treatment success: Completely… compared with NSAIDs (low certainty).

• Colchicine for acute gout 2021 · Cochrane Headline outcomes only
  RR 0.97 [0.82, 1.15]
  1 study · 399 participants
  Low

High‐dose colchicine vs placebo

High‐dose colchicine may leads to higher participant global assessment of treatment success: proportion with… compared with placebo (low certainty).

• Colchicine for acute gout 2021 · Cochrane Headline outcomes only
  RR 2.16 [1.28, 3.65]
  2 studies · 124 participants
  Low

Non‐selective NSAIDs vs selective cyclo‐oxygenase‐2 inhibitors

• Non‐steroidal anti‐inflammatory drugs for acute gout 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Moderate

NSAIDs vs glucocorticoids

NSAIDs showed no clear difference in patients' global assessment of treatment success at day 3 to 4 compared with glucocorticoids (moderate certainty).

• Non‐steroidal anti‐inflammatory drugs for acute gout 2021 · Cochrane Headline outcomes only
  RR 0.92 [0.7, 1.22]
  Studies not reported
  Moderate

NSAIDs vs placebo

• Non‐steroidal anti‐inflammatory drugs for acute gout 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Vitamin C vs allopurinol

The review found no eligible studies for this question.

• Dietary supplements for chronic gout 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Skim milk enriched with GMP/G600 vs skim milk & lactose powder

The review found no eligible studies for this question.

• Dietary supplements for chronic gout 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Kinesiotaping vs other conservative treatment

The review found no eligible studies for this question.

• Kinesio taping for rotator cuff disease 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Kinesiotaping vs sham taping

The review found no eligible studies for this question.

• Kinesio taping for rotator cuff disease 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found